These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 12569968)

  • 41. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
    Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.
    Matarasso SL
    Dermatol Surg; 2003 Jan; 29(1):7-13; discussion 13. PubMed ID: 12534505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botox for the eyes and eyebrows.
    Klein AW
    Dermatol Clin; 2004 Apr; 22(2):145-9, vi. PubMed ID: 15222574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
    Beer KR
    Dermatol Surg; 2006 Feb; 32(2):184-97. PubMed ID: 16442037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ten Mistakes To Avoid When Injecting Botulinum Toxin.
    Ruiz-Rodriguez R; Martin-Gorgojo A
    Actas Dermosifiliogr; 2015; 106(6):458-64. PubMed ID: 25956528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis.
    Goodman G
    Dermatol Surg; 2003 May; 29(5):533-8; discussion 538. PubMed ID: 12752524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW; Pijpe J; Jansma J
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial.
    Baumann L; Slezinger A; Vujevich J; Halem M; Bryde J; Black L; Duncan R
    Dermatol Surg; 2003 May; 29(5):508-15. PubMed ID: 12752519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aesthetic uses of the botulinum toxin.
    Dorizas A; Krueger N; Sadick NS
    Dermatol Clin; 2014 Jan; 32(1):23-36. PubMed ID: 24267419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myobloc.
    Flynn TC
    Dermatol Clin; 2004 Apr; 22(2):207-11, vii. PubMed ID: 15222581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New neurotoxins on the horizon.
    Freeman SR; Cohen JL
    Aesthet Surg J; 2008; 28(3):325-30. PubMed ID: 19083544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxins. Introduction.
    Klein AW
    Semin Cutan Med Surg; 2001 Jun; 20(2):69-70. PubMed ID: 11474746
    [No Abstract]   [Full Text] [Related]  

  • 55. Are there any drawbacks to smoothing out lines and wrinkles with Botox injections?
    Johns Hopkins Med Lett Health After 50; 2014 Jul; 26(6):7. PubMed ID: 25178125
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparisons among botulinum toxins: an evidence-based review.
    Klein AW; Carruthers A; Fagien S; Lowe NJ
    Plast Reconstr Surg; 2008 Jun; 121(6):413e-422e. PubMed ID: 18520868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective analysis of the uses of BoNT-A in daily dermatological practice.
    Hügül H; Özkoca D; Kutlubay Z
    J Cosmet Dermatol; 2022 May; 21(5):1948-1952. PubMed ID: 35156765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics.
    Carruthers J; Fagien S; Matarasso SL;
    Plast Reconstr Surg; 2004 Nov; 114(6 Suppl):1S-22S. PubMed ID: 15507786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Axillary hyperhidrosis, botulinium A toxin treatment: Review].
    Clerico C; Fernandez J; Camuzard O; Chignon-Sicard B; Ihrai T
    Ann Chir Plast Esthet; 2016 Feb; 61(1):60-4. PubMed ID: 25555435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin for axillary hyperhidrosis.
    de Almeida AR; Montagner S
    Dermatol Clin; 2014 Oct; 32(4):495-504. PubMed ID: 25152343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.